Related Experiment Video
Updated: Jun 24, 2026

11:30
Quantitative Analysis of Aspergillus nidulans Growth Rate using Live Microscopy and Open-Source Software
Published on: July 24, 2021
Process development in Hansenula polymorpha and Arxula adeninivorans, a re-assessment
Christoph Stöckmann1, Marco Scheidle, Barbara Dittrich
1PharmedArtis GmbH, Forckenbeckstr, 6, 52074 Aachen, Germany. gerd.gellissen@pharmedartis.de.
Microbial Cell Factories
|April 17, 2009
Summary
Industrial yeast processes for pharmaceuticals utilize Hansenula polymorpha (H. polymorpha) with specific promoters. Fermentation conditions and a synthetic medium (SYN6) were defined for H. polymorpha and Arxula adeninivorans, optimizing heterologous gene expression.
Area of Science:
- Biotechnology and Industrial Microbiology
- Yeast Genetics and Physiology
- Metabolic Engineering
Background:
- Established industrial processes for pharmaceutical production often utilize Hansenula polymorpha (H. polymorpha).
- These processes commonly employ promoters from MOX and FMD genes involved in methanol metabolism.
- Unlike other methylotrophs, H. polymorpha promoters are de-repressed by carbon source depletion (e.g., glucose, glycerol) rather than methanol induction.
Purpose of the Study:
- To define screening and fermentation strategies for H. polymorpha strains with specific expression control elements.
- To develop and adapt fermentation conditions for H. polymorpha and Arxula adeninivorans.
- To identify suitable promoter elements for heterologous gene expression in these yeasts.
Main Methods:
- Development of a synthetic minimal medium (SYN6) for H. polymorpha fermentation.
- Adaptation of SYN6 for initial fermentation condition definition in Arxula adeninivorans.
- Consideration of yeast characteristics such as osmo- and thermotolerance for culture condition optimization.
Main Results:
- Defined screening and fermentation modes for H. polymorpha based on its unique promoter de-repression characteristics.
- Established SYN6 as a suitable medium for H. polymorpha fermentation.
- Provided a basis for defining fermentation conditions for Arxula adeninivorans, addressing its specific needs.
Conclusions:
- H. polymorpha offers established industrial potential for pharmaceutical production using specific fermentation strategies.
- SYN6 medium and defined conditions support efficient fermentation for H. polymorpha.
- Further development is needed for Arxula adeninivorans, but SYN6 and consideration of its physiological traits provide a starting point for optimizing heterologous gene expression.

